Mason Morfit ValueAct Holdings
Mason Morfit is chief executive officer of ValueAct Capital, a major constructive-activist investment firm. ValueAct typically takes significant stakes in companies and works with boards on strategy, capital allocation, and operational improvement. Morfit’s campaigns and holdings are closely watched in both activist and fundamental investing communities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$616M |
| 2 |
Insight Enterprises
NSIT
|
+$176M |
| 3 |
Lumentum
LITE
|
+$81.3M |
| 4 |
BLD
TopBuild
BLD
|
+$53.5M |
| 5 |
CBRE Group
CBRE
|
+$238K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seagate
STX
|
+$508M |
| 2 |
KKR & Co
KKR
|
+$242M |
| 3 |
Trinity Industries
TRN
|
+$228M |
| 4 |
SLM Corp
SLM
|
+$113M |
| 5 |
Citigroup
C
|
+$72.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.91% |
| 2 | Technology | 28.26% |
| 3 | Consumer Discretionary | 11.75% |
| 4 | Real Estate | 9.72% |
| 5 | Healthcare | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
KKR & Co
KKR
$97.4B
| $1.61B | 17.87% |
27,221,126
-4,363,546
| -14% | -$242M |
|
|
2
Seagate
STX
$193B
| $1.53B | 16.93% |
17,377,070
-5,634,153
| -24% | -$508M |
|
|
3
Citigroup
C
$221B
| $1.47B | 16.27% |
20,745,704
-978,015
| -5% | -$72.4M |
|
4
LKQ Corp
LKQ
$6.52B
| $1.06B | 11.75% |
21,550,411
+2,665
| +0% | +$127K |
|
|
5
CBRE Group
CBRE
$44B
| $877M | 9.72% |
10,232,609
+2,789
| +0% | +$238K |
|
|
FISV
6
Fiserv Inc
FISV
$28B
| $658M | 7.3% |
6,160,200
+5,300,200
| +616% | +$616M |
|
7
Bausch Health
BHC
$2.41B
| $526M | 5.83% |
17,941,603
| – | – |
|
|
8
SLM Corp
SLM
$4.97B
| $431M | 4.78% |
20,579,254
-5,715,000
| -22% | -$113M |
|
|
9
Trinity Industries
TRN
$2.37B
| $404M | 4.47% |
15,005,855
-8,100,000
| -35% | -$228M |
|
|
10
Insight Enterprises
NSIT
$4.33B
| $284M | 3.15% |
2,843,690
+1,743,690
| +159% | +$176M |
|
|
BLD
11
DELISTED
TopBuild
BLD
| $94.9M | 1.05% |
480,000
+258,230
| +116% | +$53.5M |
|
|
12
Lumentum
LITE
$77.7B
| $79.3M | 0.88% |
+967,049
| New | +$81.3M |
|
|
CBAH.WS
13
DELISTED
CBRE Acquisition Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A co
CBAH.WS
| $20K | ﹤0.01% |
18,417
| – | – |
|
14
Outfront Media
OUT
$5.25B
| – | – |
-159,963
| Closed | -$3.44M |
|
Similar funds
Mason Morfit's Q2 2021 Portfolio in Review
As of Q2 2021, Mason Morfit held 14 positions worth $9.02B, up 5.3% from $8.57B the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Mason Morfit's Q2 2021 filing shows 1 new, 5 increased, 5 reduced and 1 closed positions. Its largest new stake was Lumentum: 967,049 shares worth $79.3M. The largest sale was Seagate, an estimated $508M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 42% a quarter earlier, followed by Technology and Consumer Discretionary.
- Mason Morfit's largest Q2 2021 buy was Lumentum: 967,049 shares worth $79.3M.
- Mason Morfit added most to Fiserv Inc in Q2 2021, an estimated $616M increase.
- Mason Morfit's biggest Q2 2021 reduction was Seagate, cutting an estimated $508M.
- Mason Morfit fully exited Outfront Media in Q2 2021, selling an estimated $3.44M.
- Mason Morfit's ten largest holdings make up 98% of its $9.02B portfolio in Q2 2021.
- Mason Morfit opened 1 new position and closed 1 in Q2 2021.
- Mason Morfit's portfolio value rose 5.3% quarter-over-quarter to $9.02B.
Based on ValueAct Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.